Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
112
Frequently Asked Questions
What is Market Cap of Kyverna Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Kyverna Therapeutics Inc. market cap is $156.98M.
What is the 52-week high for Kyverna Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kyverna Therapeutics Inc. 52 week high is $7.85 as of September 06, 2025.
What is the 52-week low for Kyverna Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kyverna Therapeutics Inc. 52 week low is $1.78 as of September 06, 2025.
What is Kyverna Therapeutics Inc. stock price today?
Kyverna Therapeutics Inc. stock price today is $3.94.
What was Kyverna Therapeutics Inc. stock price yesterday?
Kyverna Therapeutics Inc. stock price yesterday was $3.63.
What is the PE ratio of Kyverna Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Kyverna Therapeutics Inc.’s P/E ratio is -0.99.
What is the Price-to-Book ratio of Kyverna Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Kyverna Therapeutics Inc. P/B ratio is 0.8514.
What is the 50-day moving average of Kyverna Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Kyverna Therapeutics Inc. 50-day moving average is $3.56.
How many employess does Kyverna Therapeutics Inc. has?
